-
Delivering health for all: the critical role of gender-responsive health systems Lancet Global Health (IF 34.3) Pub Date : 2024-03-07 Angeli Achrekar, Svetlana Akselrod, Helen Clark, Gabriela Cuevas Barron, Michael Charles, Katie Dain, Roopa Dhatt, Maliha Khan, Justin Koonin, Ilayda Oankoy, Swostika Thapaliya, Chantal Umuhoza
-
Ending the neglect of paediatric, maternal, and congenital mpox Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nadia Adjoa Sam-Agudu, Dimie Ogoina
-
Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nuria Sanchez Clemente, Charlotte Coles, Enny S Paixao, Elizabeth B Brickley, Elizabeth Whittaker, Tobias Alfven, Stephen Rulisa, Nelson Agudelo Higuita, Paul Torpiano, Priyesh Agravat, Emma V Thorley, Simon B Drysdale, Kirsty Le Doare, Jean-Jacques Muyembe Tamfum
-
An indicator framework for the monitoring and evaluation of event-based surveillance systems Lancet Global Health (IF 34.3) Pub Date : 2024-02-13 Adam W Crawley, Kyeng Mercy, Sabrina Shivji, Hannah Lofgren, Daniella Trowbridge, Christine Manthey, Yenew Kebede Tebeje, Alexey Wil Clara, Kimberly Landry, Stephanie J Salyer
-
Correction to Lancet Glob Health 2023; 11: e1978–85 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Correction to Lancet Glob Health 2023; 11: e1713–24 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Compounding challenges for Syrian refugees in Türkiye in the wake of the earthquake Lancet Global Health (IF 34.3) Pub Date : 2024-02-07 Rasha Kaloti, Jasmin Lilian Diab, Munzer Alkhalil, Diana Rayes, Aula Abbara
-
Unveiling the crisis of the double burden of malnutrition Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Biniyam Sahiledengle, Lillian Mwanri
Abstract not available
-
The effect of nutrition-specific and nutrition-sensitive interventions on the double burden of malnutrition in low-income and middle-income countries: a systematic review Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Nora A Escher, Giovanna C Andrade, Suparna Ghosh-Jerath, Christopher Millett, Paraskevi Seferidi
Background Low-income and middle-income countries (LMICs) experiencing nutrition transition face an increasing double burden of malnutrition (DBM). WHO has urged the identification of risks and opportunities in nutrition interventions to mitigate the DBM, but robust evidence is missing. This review summarises the effect of nutrition-specific and nutrition-sensitive interventions on undernutrition and
-
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance Lancet Global Health (IF 34.3) Pub Date : 2024-01-23 Marc Mendelson, Ramanan Laxminarayan, Direk Limmathurotsakul, Samuel Kariuki, Martha Gyansa-Lutterodt, Esmita Charani, Sanjeev Singh, Kamini Walia, Ana C Gales, Mirfin Mpundu
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions
-
Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Jenny L Schnyder, Hanna K de Jong, Bache E Bache, Frieder Schaumburg, Martin P Grobusch
Background Long-term immunity following yellow fever vaccination remains controversial. We aimed to summarise the literature regarding the long-term protection (≥10 years) conveyed by a single dose of yellow fever vaccination. Methods In this systematic review and meta-analysis, we searched 11 databases from database inception to Aug 24, 2023. We included cohort and cross-sectional studies reporting
-
The life-long protective immunity of yellow fever vaccination: time to review? Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Aitana Juan-Giner, Joachim Hombach
Abstract not available
-
The urgency of identifying global priorities for hearing loss prevention Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Alessandra Giannella Samelli, Carla Gentile Matas
Abstract not available
-
Latent viral infections as neglected risk factors for long COVID Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Amir Abdoli, Ali Taghipour, Mirza Ali Mofazzal Jahromi, Fatemeh Eftekharian, Reza Sahraei, Mohammad Sadegh Sanie
Abstract not available
-
Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Kavita Prasad, Ethan D Borre, Lauren K Dillard, Austin Ayer, Carolina Der, Kathleen E Bainbridge, Catherine M McMahon, Debara L Tucci, Blake S Wilson, Gillian D Sanders Schmidler, James Saunders
Background Hearing loss affects approximately 1·6 billion individuals worldwide. Many cases are preventable. We aimed to estimate the annual number of new hearing loss cases that could be attributed to meningitis, otitis media, congenital rubella syndrome, cytomegalovirus, and ototoxic medications, specifically aminoglycosides, platinum-based chemotherapeutics, and antimalarials. Methods We used a
-
Noma: neglected no more? Lancet Global Health (IF 34.3) Pub Date : 2024-01-18
Abstract not available
-
Triage test to diagnose presumptive pulmonary tuberculosis Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Renu Verma, Kalaiarasan Ellappan, Karen E Kempsell, Noyal Mariya Joseph
Abstract not available
-
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Annelies Wilder-Smith
Abstract not available
-
Priorities to reduce the burden of hypertension in Africa through ACHIEVE Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Paul Olowoyo, Prebo Barango, Andrew Moran, Bryan Williams, Paul K Whelton, Mayowa Owolabi
Abstract not available
-
Malaria guidelines fall short in diagnosing acute kidney injury Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Anthony Batte, Valerie A Luyckx, Terrie E Taylor, Andrea L Conroy
Abstract not available
-
Latent viral infections as neglected risk factors for long COVID – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Sophie Alice Müller, Lynda Isaaka, Rebekka Mumm, Christa Scheidt-Nave, Katharina Heldt, Angela Schuster, Mohammed Abdulaziz, Charbel El-Bcheraoui, Johanna Hanefeld, Ambrose Agweyu
Abstract not available
-
Dengue vector habitats in Ouagadougou, Burkina Faso, 2020: an unintended consequence of the installation of public handwashing stations for COVID-19 prevention Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Wendegoudi M Ouédraogo, Nicolas Zanré, Noah H Rose, Julien Z B Zahouli, Luc S Djogbenou, Mafalda Viana, Hirotaka Kanuka, David Weetman, Philip J McCall, Athanase Badolo
Abstract not available
-
Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Ankur Gupta-Wright, Huy Ha, Shima Abdulgadar, Rebecca Crowder, Jerusha Emmanuel, Job Mukwatamundu, Danaida Marcelo, Patrick P J Phillips, Devasahayam Jesudas Christopher, Nguyen Viet Nhung, Grant Theron, Charles Yu, Payam Nahid, Adithya Cattamanchi, William Worodria, Claudia M Denkinger
Background Non-sputum-based triage tests for tuberculosis are a priority for ending tuberculosis. We aimed to evaluate the diagnostic accuracy of the late-prototype Xpert MTB Host Response (Xpert HR) blood-based assay. Methods We conducted a prospective diagnostic accuracy study among outpatients with presumed tuberculosis in outpatient clinics in Viet Nam, India, the Philippines, Uganda, and South
-
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Rui Zhao, Christopher K Fairley, Alex R Cook, Nittaya Phanuphak, Shiyi He, Warittha Tieosapjaroen, Eric P F Chow, Tiffany R Phillips, Rayner Kay Jin Tan, Yuhang Wei, Mingwang Shen, Guihua Zhuang, Jason J Ong, Lei Zhang
Background Men who have sex with men (MSM) in the Asia-Pacific region have a disproportionately high burden of HIV infection compared with the general population. Although pre-exposure prophylaxis (PrEP) for HIV is highly effective at preventing new HIV infections, the cost-effectiveness of PrEP for MSM in different countries in the Asia-Pacific region with varying PrEP coverage and HIV testing frequencies
-
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Vianney Tricou, Delia Yu, Humberto Reynales, Shibadas Biswal, Xavier Saez-Llorens, Chukiat Sirivichayakul, Pio Lopez, Charissa Borja-Tabora, Lulu Bravo, Pope Kosalaraksa, Luis Martinez Vargas, Maria Theresa Alera, Luis Rivera, Veerachai Watanaveeradej, Reynaldo Dietze, LakKumar Fernando, V Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D Fernando, Dulanie Gunasekera, Derek Wallace
Background About half of the world's population lives in dengue-endemic areas. We aimed to evaluate the long-term efficacy and safety of two doses of the tetravalent dengue vaccine TAK-003 in preventing symptomatic dengue disease of any severity and due to any dengue virus (DENV) serotypes in children and adolescents. Methods In this ongoing double-blind, randomised, placebo-controlled trial, we enrolled
-
Racial disparities in breast cancer survival after treatment initiation in Brazil: a nationwide cohort study Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Lívia Lovato Pires Lemos, Mirian Carvalho Souza, Augusto Afonso Guerra, Thais Piazza, Rodrigo Moura Araújo, Mariangela Leal Cherchiglia
Background Breast cancer is a public health priority in Brazil and ensuring equity in health care is one of the cancer control plan goals. Our aim was to present the first assessment on the influence of race or skin colour on breast cancer survival at the national level. Methods In this nationwide cohort study, data on women who initiated treatment for breast cancer in the public health-care system
-
Correction to Lancet Glob Health 2022; 10: 1715–43 Lancet Global Health (IF 34.3) Pub Date : 2024-01-17
Abstract not available
-
Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a model-based cost-effectiveness analysis of a pragmatic, cluster-randomised trial in seven low-income and middle-income countries Lancet Global Health (IF 34.3) Pub Date : 2024-01-18
Background Surgical site infection (SSI) is a major burden on patients and health systems. This study assessed the cost-effectiveness of routine change of sterile gloves and instruments before abdominal wall closure to prevent SSI. Methods A decision-analytic model was built to estimate average costs and outcomes of changing gloves and instruments before abdominal wall closure compared with current
-
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Benjamin R Bavinton, Nila J Dharan
Abstract not available
-
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry Lancet Global Health (IF 34.3) Pub Date : 2024-01-11 Marjan Walli-Attaei, Philip Joseph, Isabelle Johansson, Karen Sliwa, Eva Lonn, Aldo P Maggioni, Lisa Mielniczuk, Heather Ross, Kamilu Karaye, Camilla Hage, Nana Pogosova, Alex Grinvalds, Tara McCready, John McMurray, Salim Yusuf
Background There is a paucity of data on the clinical characteristics, management, and outcomes of women compared with men with heart failure in low-income and middle-income countries compared with high-income countries. We examined sex differences in risk factors, clinical characteristics, and treatments, and prospectively assessed the risk of heart failure hospitalisation and mortality in patients
-
Learning from our differences: insights from a global heart failure registry Lancet Global Health (IF 34.3) Pub Date : 2024-01-11 Sandhir B Prasad, John J Atherton
Abstract not available
-
Correction to Lancet Glob Health 2024; 12: e25–27 Lancet Global Health (IF 34.3) Pub Date : 2024-01-08
Abstract not available
-
A research definition and framework for acute paediatric critical illness across resource-variable settings: a modified Delphi consensus Lancet Global Health (IF 34.3) Pub Date : 2024-01-05 Anita V Arias, Michael Lintner-Rivera, Nadeem I Shafi, Qalab Abbas, Abdelhafeez H Abdelhafeez, Muhammad Ali, Halaashuor Ammar, Ali I Anwar, John Adabie Appiah, Jonah E Attebery, Willmer E Diaz Villalobos, Daiane Ferreira, Sebastián González-Dambrauskas, Muhammad Irfan Habib, Jan Hau Lee, Niranjan Kissoon, Atnafu M Tekleab, Elizabeth M Molyneux, Brenda M Morrow, Vinay M Nadkarni, Asya Agulnik
The true global burden of paediatric critical illness remains unknown. Studies on children with life-threatening conditions are hindered by the absence of a common definition for acute paediatric critical illness (DEFCRIT) that outlines components and attributes of critical illness and does not depend on local capacity to provide critical care. We present an evidence-informed consensus definition and
-
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study Lancet Global Health (IF 34.3) Pub Date : 2023-12-21 Kwabena Asare, Yukteshwar Sookrajh, Johan van der Molen, Thokozani Khubone, Lara Lewis, Richard J Lessells, Kogieleum Naidoo, Phelelani Sosibo, Rosemary van Heerden, Nigel Garrett, Jienchi Dorward
Background Dolutegravir (DTG) is recommended for second-line antiretroviral therapy (ART) after virological failure on first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens in people living with HIV in low-income and middle-income countries. We compared the effectiveness of DTG versus the previously recommended ritonavir-boosted lopinavir (LPV/r) regimen for second-line treatment
-
Dolutegravir for second-line antiretroviral therapy: the beat goes on Lancet Global Health (IF 34.3) Pub Date : 2023-12-21 Nosipho Shangase, Tendesayi Kufa
Abstract not available
-
Bacterial antimicrobial resistance burden in Africa: accuracy, action, and alternatives Lancet Global Health (IF 34.3) Pub Date : 2023-12-19 Sabiha Y Essack, Annick Lenglet
Abstract not available
-
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis Lancet Global Health (IF 34.3) Pub Date : 2023-12-19
Background A critical and persistent challenge to global health and modern health care is the threat of antimicrobial resistance (AMR). Previous studies have reported a disproportionate burden of AMR in low-income and middle-income countries, but there remains an urgent need for more in-depth analyses across Africa. This study presents one of the most comprehensive sets of regional and country-level
-
Navigating TREAT-B in resource-limited settings Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Anna Kramvis, Daryl T Y Lau
Abstract not available
-
Correction to Lancet Glob Health 2023; 11: e1922–30 Lancet Global Health (IF 34.3) Pub Date : 2023-12-12
Abstract not available
-
Oral swabs with a rapid molecular diagnostic test for pulmonary tuberculosis in adults and children: a systematic review Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 E Chandler Church, Karen R Steingart, Gerard A Cangelosi, Morten Ruhwald, Mikashmi Kohli, Adrienne E Shapiro
Background Tuberculosis is a leading cause of infectious disease mortality worldwide, but diagnosis of pulmonary tuberculosis remains challenging. Oral swabs are a promising non-sputum alternative sample type for the diagnosis of pulmonary tuberculosis. We aimed to assess the diagnostic accuracy of oral swabs to detect pulmonary tuberculosis in adults and children and suggest research implications
-
Postnatal morbidity: prevalent, enduring, and neglected Lancet Global Health (IF 34.3) Pub Date : 2023-12-12
Abstract not available
-
Post-discharge malaria chemoprevention in children with severe anaemia: a robust strategy to save lives Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Marc Christian Tahita, Quique Bassat
Abstract not available
-
Defining the usefulness of oral swabs in tuberculosis diagnosis Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Helena Rabie, Marieke M van Der Zalm
Abstract not available
-
Chronic non-communicable diseases in sub-Saharan Africa Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Alisha N Wade
Abstract not available
-
Introduction to The Lancet Global Health's Series on the People's Voice Survey on Health System Performance Lancet Global Health (IF 34.3) Pub Date : 2023-12-11 Margaret E Kruk, Todd P Lewis
Abstract not available
-
The AlignMNH 2023 Conference: progress in raising parents’ voices in stillbirth advocacy Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Grace Mwashigadi, Treasure Lwantale, Aleena M Wojcieszek, Hannah Blencowe, Susannah Hopkins Leisher, Caroline Wanjiru Kiunga, David Wanjala, Claire Storey
Abstract not available
-
The AlignMNH 2023 Conference: progress in raising parents’ voices in stillbirth advocacy Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Bridget Hartnett, Laura Fitzgerald, Anita Gibson, Charlene Reynolds
Abstract not available
-
Randomised recruitment in estimating genital human papillomavirus prevalence Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Dan Shan, Yuxuan He, Yi Chen
Abstract not available
-
Randomised recruitment in estimating genital human papillomavirus prevalence – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Laia Bruni, Ginesa Albero, Jane Rowley, Melanie Taylor, Nathalie Broutet
Abstract not available
-
Correction to Lancet Glob Health 2024; 12: e20–21 Lancet Global Health (IF 34.3) Pub Date : 2023-12-12
Abstract not available
-
Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Kamija S Phiri, Carole Khairallah, Titus K Kwambai, Kalifa Bojang, Aggrey Dhabangi, Robert Opoka, Richard Idro, Kasia Stepniewska, Michael Boele van Hensbroek, Chandy C John, Bjarne Robberstad, Brian Greenwood, Feiko O ter Kuile
Background Severe anaemia is associated with high in-hospital mortality among young children. In malaria-endemic areas, surviving children also have an increased risk of mortality or readmission after hospital discharge. We conducted a systematic review and individual patient data meta-analysis to determine the efficacy of monthly post-discharge malaria chemoprevention in children recovering from severe
-
Prevalence of hypertension, diabetes, obesity, multimorbidity, and related risk factors among adult Gambians: a cross-sectional nationwide study Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Modou Jobe, Islay Mactaggart, Suzannah Bell, Min J Kim, Abba Hydara, Covadonga Bascaran, Modou Njai, Omar Badjie, Pablo Perel, Andrew M Prentice, Matthew J Burton
Background As countries progress through economic and demographic transition, chronic non-communicable diseases (NCDs) overtake a previous burden of infectious diseases. We investigated the prevalence of hypertension, diabetes, obesity, and multimorbidity in older adults in The Gambia. Methods We embedded a survey on NCDs into the nationally representative 2019 Gambia National Eye Health Survey of
-
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 Liem B Luong Nguyen, Maud Lemoine, Gibril Ndow, Zachary J Ward, Timothy B Hallet, Umberto D’Alessandro, Mark Thursz, Shevanthi Nayagam, Yusuke Shimakawa
Background Global elimination of hepatitis B virus (HBV) requires expanded uptake of antiviral therapy, potentially by simplifying testing algorithms, especially in resource-limited countries. We evaluated the effectiveness, cost-effectiveness, and budget impact of three strategies that determine eligibility for anti-HBV treatment, as compared with the WHO 2015 treatment eligibility criteria, in The
-
Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey Lancet Global Health (IF 34.3) Pub Date : 2023-12-11 Margaret E Kruk, Neena R Kapoor, Todd P Lewis, Catherine Arsenault, Eleni C Boutsikari, João Breda, Susanne Carai, Kevin Croke, Rashmi Dayalu, Günther Fink, Patricia J Garcia, Munir Kassa, Sailesh Mohan, Mosa Moshabela, Jacinta Nzinga, Juhwan Oh, Emelda A Okiro, Dorairaj Prabhakaran, Gillian K SteelFisher, Rosanna Tarricone, Ezequiel Garcia-Elorrio
Population confidence is essential to a well functioning health system. Using data from the People's Voice Survey—a novel population survey conducted in 15 low-income, middle-income, and high-income countries—we report health system confidence among the general population and analyse its associated factors. Across the 15 countries, fewer than half of respondents were health secure and reported being
-
User-reported quality of care: findings from the first round of the People's Voice Survey in 14 countries Lancet Global Health (IF 34.3) Pub Date : 2023-12-11 Todd P Lewis, Munir Kassa, Neena R Kapoor, Catherine Arsenault, Rodrigo Bazua-Lobato, Rashmi Dayalu, Günther Fink, Theodros Getachew, Prashant Jarhyan, Hwa-Young Lee, Agustina Mazzoni, Jesus Medina-Ranilla, Inbarani Naidoo, Ashenif Tadele, Margaret E Kruk
High-quality care is essential for improving health outcomes, although many health systems struggle to maintain good quality. We use data from the People's Voice Survey—a nationally representative survey conducted in 14 high-income, middle-income, and low-income countries—to describe user-reported quality of most recent health care in the past 12 months. We described ratings for 14 measures of care
-
Inequalities in health system coverage and quality: a cross-sectional survey of four Latin American countries Lancet Global Health (IF 34.3) Pub Date : 2023-12-11 Javier Roberti, Hannah H Leslie, Svetlana V Doubova, Jesús Medina Ranilla, Agustina Mazzoni, Laura Espinoza, Renzo Calderón, Catherine Arsenault, Ezequiel García-Elorrio, Patricia J García
The premise of health as a human right in Latin America has been challenged by health system fragmentation, quality gaps, a growing burden of chronic disease, sociopolitical upheaval, and the COVID-19 pandemic. We characterised inequities in health system quality in Colombia, Mexico, Peru, and Uruguay. We did a cross-sectional telephone survey with up to 1250 adults in each country. We created binary
-
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries Lancet Global Health (IF 34.3) Pub Date : 2023-12-11 Catherine Arsenault, Todd P Lewis, Neena R Kapoor, Emelda A Okiro, Hannah H Leslie, Patrizio Armeni, Prashant Jarhyan, Svetlana V Doubova, Katherine D Wright, Amit Aryal, Sengchanh Kounnavong, Sailesh Mohan, Emily Odipo, Hwa-Young Lee, Jeonghyun Shin, Wondimu Ayele, Jesús Medina-Ranilla, Laura Espinoza-Pajuelo, Anagaw Derseh Mebratie, Ezequiel García Elorrio, Margaret E Kruk
The social and behavioural determinants of COVID-19 vaccination have been described previously. However, little is known about how vaccinated people use and rate their health system. We used surveys conducted in 14 countries to study the health system correlates of COVID-19 vaccination. Country-specific logistic regression models were adjusted for respondent age, education, income, chronic illness
-
Vaccinating international seafarers during the COVID-19 pandemic Lancet Global Health (IF 34.3) Pub Date : 2023-12-12 David Lucas, Sue Stannard, Natalie Shaw, Rob Verbist, Kevin Walker, Jason Zuidema
Despite their key role in the distribution of essential goods, seafarers were often overlooked in international COVID-19 responses. Border closures isolated them at sea, often for months beyond contract. Distributing vaccines to seafarers was inconsistent and often depended on the creativity of charities and industry and labour stakeholders. Even seafarers who received vaccinations often had them unrecognised
-
Declining prevalence of child marriage: reconfiguration and refinement Lancet Global Health (IF 34.3) Pub Date : 2023-12-15 Chander Shekhar
Abstract not available
-
Prevalence of girl and boy child marriage across states and Union Territories in India, 1993–2021: a repeated cross-sectional study Lancet Global Health (IF 34.3) Pub Date : 2023-12-15 Jewel Gausman, Rockli Kim, Akhil Kumar, Shamika Ravi, S V Subramanian
Background India's success in eliminating child marriage is crucial to the achievement of the Sustainable Development Goal target 5.3. We aimed to estimate the prevalence of child marriage in girls and boys in India and describe its change across 36 states and Union Territories between 1993 and 2021. Methods For this cross-sectional study, data from five National Family Health Surveys from 1993, 1999